In parallel, Tmem26 levels were significantly increased in cancer patients compared to controls (median 1.51 IQR 0.76; 2.03 vs. 0.77 IQR 0.41; 0.99) (p = 0.026) (Figure 1A). The gene discussed is TMEM26; the disease is cancer.